Guggulsterone-releasing microspheres direct the differentiation of human induced pluripotent stem cells into neural phenotypes

Parkinson's disease (PD), a common neurodegenerative disorder, results from the loss of motor function when dopaminergic neurons (DNs) in the brain selectively degenerate. While pluripotent stem cells (PSCs) show promise for generating replacement neurons, current protocols for generating terminally differentiated DNs require a complicated cocktail of factors. Recent work demonstrated that a naturally occurring steroid called guggulsterone effectively differentiated PSCs into DNs, simplifying this process. In this study, we encapsulated guggulsterone into novel poly-ε-caprolactone-based microspheres and characterized its release profile over 44 d in vitro, demonstrating we can control its release over time. These guggulsterone-releasing microspheres were also successfully incorporated in human induced pluripotent stem cell-derived cellular aggregates under feeder-free and xeno-free conditions and cultured for 20 d to determine their effect on differentiation. All cultures stained positive for the early neuronal marker TUJ1 and guggulsterone microsphere-incorporated aggregates did not adversely affect neurite length and branching. Guggulsterone microsphere incorporated aggregates exhibited the highest levels of TUJ1 expression as well as high Olig 2 expression, an inhibitor of the STAT3 astrogenesis pathway previously known as a target for guggulsterone in cancer treatment. Together, this study represents an important first step towards engineered neural tissues consisting of guggulsterone microspheres and PSCs for generating DNs that could eventually be evaluated in a pre-clinical model of PD.

[1]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[2]  R. Beddington,et al.  Nodal signalling in the epiblast patterns the early mouse embryo , 2001, Nature.

[3]  Salvador Martinez,et al.  Midbrain development induced by FGF8 in the chick embryo , 1996, Nature.

[4]  Louise C. Laurent,et al.  Deriving dopaminergic neurons for clinical use. A practical approach , 2013, Scientific Reports.

[5]  V. Guarino,et al.  Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic , 2008 .

[6]  Yi-Ching Lee,et al.  Interplay between SIN3A and STAT3 Mediates Chromatin Conformational Changes and GFAP Expression during Cellular Differentiation , 2011, PloS one.

[7]  O. Lindvall,et al.  Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. , 2012, Cell reports.

[8]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[9]  H. Alpár,et al.  PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods. , 1998, Journal of microencapsulation.

[10]  Omar Qutachi,et al.  Delivery of definable number of drug or growth factor loaded poly(DL-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[11]  T. McDevitt,et al.  Microsphere size effects on embryoid body incorporation and embryonic stem cell differentiation. , 2010, Journal of biomedical materials research. Part A.

[12]  R. Kaushik,et al.  Poly-epsilon-caprolactone microspheres and nanospheres: an overview. , 2004, International journal of pharmaceutics.

[13]  Elaine Fuchs,et al.  Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Ashutosh Kumar Singh,et al.  A microparticle approach to morphogen delivery within pluripotent stem cell aggregates. , 2013, Biomaterials.

[15]  Hong Li,et al.  Dynamic signaling for neural stem cell fate determination , 2009, Cell adhesion & migration.

[16]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[17]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[18]  K. Mahadik,et al.  HPTLC method for guggulsterone. II. Stress degradation studies on guggulsterone. , 2004, Journal of pharmaceutical and biomedical analysis.

[19]  F. Johansson,et al.  Three-dimensional functional human neuronal networks in uncompressed low-density electrospun fiber scaffolds. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[20]  Junghyuk Ko,et al.  Electrospun biomaterial scaffolds with varied topographies for neuronal differentiation of human-induced pluripotent stem cells. , 2015, Journal of biomedical materials research. Part A.

[21]  Ross A. Marklein,et al.  Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules. , 2009, Biomaterials.

[22]  M. Tomishima,et al.  Efficient derivation of functional floor plate tissue from human embryonic stem cells. , 2010, Cell stem cell.

[23]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[24]  J. Rossant,et al.  Spatial and temporal patterns of ERK signaling during mouse embryogenesis , 2003, Development.

[25]  Wolfgang Wurst,et al.  The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum , 2003, Development.

[26]  B. Aggarwal,et al.  Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. , 2008, Cancer research.

[27]  Shin Jung,et al.  Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. , 2003, International journal of pharmaceutics.

[28]  P. Rathjen,et al.  Reversible programming of pluripotent cell differentiation. , 2000, Journal of cell science.

[29]  J. Hanna,et al.  Dynamic stem cell states: naive to primed pluripotency in rodents and humans , 2016, Nature Reviews Molecular Cell Biology.

[30]  M. Soleimani,et al.  Influence of oriented nanofibrous PCL scaffolds on quantitative gene expression during neural differentiation of mouse embryonic stem cells. , 2016, Journal of biomedical materials research. Part A.

[31]  G. O’Keeffe,et al.  Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. , 2013, Developmental biology.

[32]  E. Sachlos,et al.  Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. , 2008, Biomaterials.

[33]  P. Chambon,et al.  Retinoic acid synthesis and hindbrain patterning in the mouse embryo. , 2000, Development.

[34]  S. Fahn.  The medical treatment of Parkinson disease from James Parkinson to George Cotzias , 2015, Movement disorders : official journal of the Movement Disorder Society.

[35]  N. K. Mohtaram,et al.  Incorporation of Retinoic Acid Releasing Microspheres into Pluripotent Stem Cell Aggregates for Inducing Neuronal Differentiation , 2015 .

[36]  R. Barker,et al.  Cell therapies for Parkinson's disease: how far have we come? , 2016, Regenerative medicine.

[37]  Peter W Zandstra,et al.  Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. , 2011, Biomaterials.

[38]  I. Cobos,et al.  FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar development via a repressive effect on Otx2 expression. , 1999, Development.

[39]  Tze-Wen Chung,et al.  Enhancing growth and proliferation of human gingival fibroblasts on chitosan grafted poly (ε-caprolactone) films is influenced by nano-roughness chitosan surfaces , 2009, Journal of materials science. Materials in medicine.

[40]  K. Tomita,et al.  Regulation of mammalian neural development by helix-loop-helix transcription factors. , 1995, Critical reviews in neurobiology.

[41]  Bin Li,et al.  Influence of carboxyl group density on neuron cell attachment and differentiation behavior: gradient-guided neurite outgrowth. , 2005, Biomaterials.

[42]  R. Jove,et al.  Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  H. Takebayashi,et al.  Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway , 2004, Cell Death and Differentiation.

[44]  M. Mozetič,et al.  Cell Adhesion on Polycaprolactone Modified by Plasma Treatment , 2016 .

[45]  W. Murphy,et al.  Mineral particles modulate osteo-chondrogenic differentiation of embryonic stem cell aggregates. , 2016, Acta biomaterialia.

[46]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[47]  L. R. Beck,et al.  Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel , 1985, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[48]  P. Vermette,et al.  Enhanced smooth muscle cell adhesion and proliferation on protein-modified polycaprolactone-based copolymers. , 2009, Journal of biomedical materials research. Part A.

[49]  Wei Sun,et al.  Accelerated differentiation of osteoblast cells on polycaprolactone scaffolds driven by a combined effect of protein coating and plasma modification , 2010, Biofabrication.

[50]  Mi-Ryoung Song,et al.  STAT3 but Not STAT1 Is Required for Astrocyte Differentiation , 2014, PloS one.

[51]  Stephanie M. Willerth,et al.  Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications , 2015, Biomarker insights.

[52]  J. Jankovic,et al.  Current approaches to the treatment of Parkinson’s disease , 2008, Neuropsychiatric disease and treatment.

[53]  A. Joyner,et al.  Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development , 2008, Development.

[54]  Todd C McDevitt,et al.  Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation , 2009, Biotechnology progress.

[55]  Michael S Kallos,et al.  Mass Transfer Limitations in Embryoid Bodies during Human Embryonic Stem Cell Differentiation , 2012, Cells Tissues Organs.

[56]  J. Miyasaki.  Treatment of Advanced Parkinson Disease and Related Disorders , 2016, Continuum.

[57]  Daniel W Pack,et al.  Microspheres for controlled release drug delivery , 2004, Expert opinion on biological therapy.

[58]  G. Castelo-Branco,et al.  GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons , 2004, Journal of Cell Science.

[59]  M. Zandi,et al.  Cell Attachment and Viability Study of PCL Nano-fiber Modified by Cold Atmospheric Plasma , 2015, Cell Biochemistry and Biophysics.

[60]  G. Castelo-Branco,et al.  GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. , 2004, Journal of cell science.

[61]  R. Sirianni,et al.  Tailoring sub-micron PLGA particle release profiles via centrifugal fractioning. , 2016, Journal of biomedical materials research. Part A.

[62]  R. Kaushik,et al.  Poly-ϵ-caprolactone microspheres and nanospheres: an overview , 2004 .

[63]  N. K. Mohtaram,et al.  Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres , 2014, Drug Delivery and Translational Research.

[64]  E. Arenas,et al.  How to make a midbrain dopaminergic neuron , 2015, Development.

[65]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[66]  Yi Yan Yang,et al.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. , 2001, Biomaterials.

[67]  Robert Langer,et al.  Human Embryoid Bodies Containing Nano‐ and Microparticulate Delivery Vehicles , 2008 .

[68]  Todd C McDevitt,et al.  Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. , 2011, Acta biomaterialia.

[69]  Chun-Xia Zhao,et al.  Multiphase flow microfluidics for the production of single or multiple emulsions for drug delivery. , 2013, Advanced drug delivery reviews.